Skip to main content
Cellid Co., Ltd. logo

Cellid Co., Ltd. — Investor Relations & Filings

Ticker · 299660 ISIN · KR7299660001 KO Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2019-10-31 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 299660

About Cellid Co., Ltd.

http://www.cellid.co.kr

Cellid Co., Ltd. is a research and development biotechnology company focused on immunotherapeutic vaccines. The company's activities are centered on two proprietary technology platforms: CeliVax for anti-cancer immunotherapy and an adenovirus vector platform for infectious disease vaccines. The CeliVax platform is used to develop personalized vaccines that utilize a patient's own B cells and monocytes to target specific cancer antigens. The adenovirus vector platform enables the rapid development of safe, non-replicating viral vector vaccines, with a key application being its COVID-19 vaccine candidate. Cellid's pipeline is built upon these core technologies to address unmet medical needs in oncology and virology.

Recent filings

Filing Released Lang Actions
주식매수선택권행사
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing from the company Cellid regarding the exercise of stock options (주식매수선택권행사). It details the number of shares exercised, the exercise price, the impact on total shares, and the schedule for new share listing. This type of disclosure regarding the issuance of new shares resulting from stock option exercises falls under the category of share capital changes.
2019-10-31 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, time, location, purpose, and contact information for the meeting. It does not contain the actual presentation slides or detailed financial analysis, but rather serves as a notification of the event. According to the 'Menu vs Meal' rule, since this is a short announcement of an event/presentation rather than the presentation itself, it falls under the category of a regulatory announcement or report publication/event notice.
2019-10-07 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange titled 'Report on the Granting of Stock Options' (주식매수선택권 부여에 관한 신고). It details the issuance of stock options to employees, including the number of shares, exercise price, and vesting conditions. This type of disclosure regarding capital structure changes and equity-based compensation for employees/directors falls under the category of share issues or capital changes.
2019-09-10 Korean
반기보고서 (2019.06)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Semi-Annual Report' (반기보고서) for the company 'Cellid' (주식회사 셀리드) covering the period from January 1, 2019, to June 30, 2019. It contains detailed financial information, business descriptions, capital changes, and management details, which are characteristic of an interim financial report. It is not an announcement of a report, but the report itself, and it is not a certification document. H1 2019
2019-08-14 Korean
주요사항보고서(유형자산양수결정)
Capital/Financing Update Classification · 95% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding the decision to acquire tangible assets (real estate). This type of filing is a mandatory regulatory disclosure for material corporate events that do not fall into specific categories like earnings or dividends. Therefore, it is classified as a Regulatory Filing (RNS).
2019-08-06 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Cellid' (주식회사 셀리드) covering the period from January 1, 2019, to March 31, 2019. It contains detailed financial information, business descriptions, capital changes, and management details, which are characteristic of an interim financial report. According to the provided definitions, this falls under the 'Interim / Quarterly Report' (IR) category. Q1 2019
2019-05-15 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.